SPY423.13+2.27 0.54%
DIA339.50+0.72 0.21%
IXIC14,253.27+111.79 0.79%

--RBC Boosts Price Target on Intra-Cellular Therapies to $47 From $44, Maintains Outperform Rating

05/11/2021 05:11

09:04 AM EDT, 05/11/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 35.85, Change: -0.12, Percent Change: -0.33